SOLU-MEDROL Drug Patent Profile
✉ Email this page to a colleague
When do Solu-medrol patents expire, and when can generic versions of Solu-medrol launch?
Solu-medrol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in SOLU-MEDROL is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Solu-medrol
A generic version of SOLU-MEDROL was approved as methylprednisolone sodium succinate by FRESENIUS KABI USA on July 30th, 2004.
Summary for SOLU-MEDROL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 39 |
| Clinical Trials: | 120 |
| Patent Applications: | 4,026 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for SOLU-MEDROL |
| What excipients (inactive ingredients) are in SOLU-MEDROL? | SOLU-MEDROL excipients list |
| DailyMed Link: | SOLU-MEDROL at DailyMed |
See drug prices for SOLU-MEDROL
Recent Clinical Trials for SOLU-MEDROL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Emory University | Phase 4 |
| Northwestern University | Phase 4 |
| Rush University Medical Center | Phase 4 |
Pharmacology for SOLU-MEDROL
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for SOLU-MEDROL
US Patents and Regulatory Information for SOLU-MEDROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | SOLU-MEDROL | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 011856-006 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Pharmacia And Upjohn | SOLU-MEDROL | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 011856-004 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Pharmacia And Upjohn | SOLU-MEDROL | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 011856-007 | Feb 27, 1985 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Pharmacia And Upjohn | SOLU-MEDROL | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 011856-003 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Pharmacia And Upjohn | SOLU-MEDROL | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 011856-005 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
